HUYABIO International

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, HUYABIO International sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 2 completed early-phase tilt upper quartile by trial count

HUYABIO International: 7 sponsored US clinical trials, none currently recruiting.

HUYABIO International sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer of Pancreas, with 2 trials.

Upper-quartile sponsor footprint

HUYABIO International sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 1

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

NCT05485974
ACTIVE NOT RECRUITING Phase 1

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

NCT05163028
ACTIVE NOT RECRUITING Phase 3

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

NCT04674683
ACTIVE NOT RECRUITING Phase 2

A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)

NCT04680026
TERMINATED Phase 2

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

NCT05141357
COMPLETED Phase 1

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

NCT04650542
COMPLETED Phase 1

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 2
Phase 3 1

Therapeutic Areas

Cancer of Pancreas 2
Colorectal Cancer 2
Non-Small Cell Lung Cancer 2
Solid Tumor 2
Cancer 2
Progressive Brain Metastasis 1
Unresectable or Metastatic Melanoma 1
Cancer of Colon 1
Colon Cancer 1
Pancreatic Cancer 1

How the HUYABIO International early-phase archive is shaped

7 indexed studies, none listed as recruiting (0% open); 2 completed (29%).

Phase mix: 1 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Cancer of Pancreas (2 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

HUYABIO International: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

HUYABIO International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share HUYABIO International3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
HUYABIO International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

HUYABIO International sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this HUYABIO International page

7 registered trials is a research-attention snapshot, not an endorsement of HUYABIO International or any single study.

  • None of HUYABIO International's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cancer of Pancreas is the condition HUYABIO International studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer of Pancreas trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. HUYABIO International pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.